New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine-Reference-Cited by-同舟云学术

New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine

Published:2021-05-13 Issue:6 Volume:30 Page:635-652
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Lescoat Alain¹²³⁴,Varga John¹²,Matucci-Cerinic Marco⁵,Khanna Dinesh¹²

Affiliation:

1. Department of internal medicine, Division of rheumatology and Michigan Scleroderma Program, University of Michigan, Ann Arbor, Michigan, USA

2. Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA

3. Department of internal medicine, Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut De Recherche En Santé, Environnement Et Travail) - UMR_S 1085, Rennes, France

4. Department of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes, France

5. Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Florence, Italy

Funder

French network of the University Hospitals HUGO

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2021.1923693

Reference186 articles.

1. Systemic sclerosis

2. Systemic sclerosis: a prototypic multisystem fibrotic disorder

3. Raynaud phenomenon and digital ulcers in systemic sclerosis

4. Systemic sclerosis

5. Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulation of TNF‐induced protein 3 and CCAAT/enhancer‐binding protein β in alveolar macrophages: Implications for systemic sclerosis‐associated interstitial lung disease;International Journal of Rheumatic Diseases;2024-05

2. TANGO1 inhibitors reduce collagen secretion and limit tissue scarring;Nature Communications;2024-04-24

3. Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis;Molecular Aspects of Medicine;2024-04

4. The Rising Challenge of Poor Health Literacy of Patients with Systemic Sclerosis: Preliminary Data Identify Important Unmet Needs in an Italian Cohort;Nursing Reports;2024-03-05

5. A Mechanistic Approach to Understanding and Preventing the Vasculopathy of Raynaud’s Phenomenon;Raynaud’s Phenomenon;2024